Streetbeat News

Price Targets

CROX

Raymond James analyst Rick Patel has upgraded Crocs (NASDAQ:CROX) from Market Perform to Outperform and set a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:23 pm

MAT

Citigroup analyst James Hardiman has initiated coverage on Mattel (NASDAQ:MAT) with a Buy rating and a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:17 pm

LSPD

Morgan Stanley analyst Josh Baer has maintained an Equal-Weight rating on Lightspeed Commerce (NYSE:LSPD) and lowered the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:16 pm

KNX

Morgan Stanley analyst Ravi Shanker has maintained an Overweight rating on Knight-Swift (NYSE:KNX) and raised the price target from $70 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:14 pm

FCX

Morgan Stanley analyst Carlos De Alba has maintained an Equal-Weight rating on Freeport-McMoRan (NYSE:FCX) and lowered the price target from $44 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:12 pm

FITB

Morgan Stanley analyst Manan Gosalia maintains an Equal-Weight rating on Fifth Third Bancorp (NASDAQ:FITB) and raises the price target from $28 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:11 pm

EFX

Morgan Stanley analyst Toni Kaplan has maintained an Equal-Weight rating on Equifax (NYSE:EFX) and lowered the price target from $204 to $196.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:09 pm

NVST

Morgan Stanley analyst Drew Ranieri has maintained an Overweight rating on Envista Holdings (NYSE:NVST) but lowered the price target from $46 to $42.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:07 pm

DFS

Morgan Stanley analyst Betsy Graseck has maintained an Equal-Weight rating on Discover Financial Services (NYSE:DFS) but lowered the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:04 pm

PFE

UBS analyst Colin Bristow has assumed Pfizer (NYSE:PFE) with a Neutral rating and lowered the price target to $34.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 12:02 pm